Qnovia Inc: Valuation, Funding & Investors
https://www.qnovia.com/Therapeutics
Qnovia Inc. is a pharmaceutical company specializing in the development of prescription inhaled smoking cessation medications. The company is advancing its RespiRx™ Nicotine Inhaler, which recently received clearance from the U.S. FDA for its Investigational New Drug application, towards commercialization in the UK.
Leadership & Board
- Current Number of Employees
- 13
- Current LinkedIn Followers
- 764
Latest Estimated Valuation
- Total Amount Raised
- $16M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $16M
- Latest Funding Round
- Series B
Employee Trend
Qnovia Inc had 13 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
13Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Qnovia Inc had 764 followers as of November 16, 2026. The number of followers increased by 1 (0.13%) week-over-week.
764Latest Followers Count
1(0.13%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Series B | $16.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Gaingels | Series B |
| Blue Ledge Capital | Series B |
| Evolution VC Partners | Series B |
| Vice Ventures | Series B |
Similar Companies
A snapshot of private companies similar to Qnovia Inc, helping you discover and navigate related company profiles.






